Source: Eur Respir J 2013; 41: 1292-1301
Disease area: Airway diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Judith Hurdman, Robin Condliffe, Charlie A. Elliot, Andrew Swift, Smitha Rajaram, Christine Davies, Catherine Hill, Neil Hamilton, Iain J. Armstrong, Catherine Billings, Lauren Pollard, Jim M. Wild, Allan Lawrie, Rod Lawson, Ian Sabroe, David G. Kiely. Pulmonary hypertension in COPD: results from the ASPIRE registry. Eur Respir J 2013; 41: 1292-1301

Member's Comments

No comment yet.

Related content which might interest you: Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 The acute effect of budesonide/formoterol in COPD: a multi-slice computed tomography and lung function study Source: Eur Respir J 2012; 40: 298-305 Year: 2012 Prevalence and clinical correlates of bronchoreversibility in severe emphysema Source: Eur Respir J 2010; 35: 1048-1056 Year: 2010 The extent of emphysema in patients with COPD Source: Annual Congress 2006 - COPD: imaging and computer applications Year: 2006 Pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD): Preliminary data of a longitudinal survey Source: International Congress 2014 – Clinical presentations Year: 2014 Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome Source: Eur Respir J 2010; 35: 105-111 Year: 2010 Predominant emphysema phenotype in chronic obstructive pulmonary disease patients Source: Eur Respir J 2003; 21: 450-454 Year: 2003 Regional ventilatory defects in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2006 - COPD: imaging and computer applications Year: 2006 Comparison of CT scan-measured pulmonary artery to aorta ratio of combined pulmonary fibrosis and emphysema (CPFE) and COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Conclusion: treatment of pulmonary hypertension in COPD patients Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange Year: 2005 The prevalence and characteristics of pulmonary hypertension in severe COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Effect of obstructive lung disease on mosaic attenuation patern in CTEPH patient Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema Source: Eur Respir J 2011; 37: 176-183 Year: 2011 Comparison of pulmonary hypertension (PH) associated to chronic lung disease to other PH groups Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Systemic vascular function in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Utility of echocardiography in assessment of pulmonary hypertension secondary to COPD Source: Eur Respir J 2001; 17: 350-355 Year: 2001 Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 40: 93-100 Year: 2012 Patterns of cardiopulmonary response to exercise in lung diseases Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-49-5, page=69 Year: 2007 Quantitative image analysis Source: Annual Congress 2007 - Results of the international endobronchial valve for emphysema palliation trial (VENT) Year: 2007